168 related articles for article (PubMed ID: 30535445)
1. Hypoxia‑induced galectin‑3 enhances RhoA function to activate the motility of tumor cells in non‑small cell lung cancer.
Kataoka Y; Ohshio Y; Teramoto K; Igarashi T; Asai T; Hanaoka J
Oncol Rep; 2019 Feb; 41(2):853-862. PubMed ID: 30535445
[TBL] [Abstract][Full Text] [Related]
2. Predictive importance of galectin-3 for recurrence of non-small cell lung cancer.
Kataoka Y; Igarashi T; Ohshio Y; Fujita T; Hanaoka J
Gen Thorac Cardiovasc Surg; 2019 Aug; 67(8):704-711. PubMed ID: 30903521
[TBL] [Abstract][Full Text] [Related]
3. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
4. Cullin 3 overexpression inhibits lung cancer metastasis and is associated with survival of lung adenocarcinoma.
Zhou J; Zhang S; Xu Y; Ye W; Li Z; Chen Z; He Z
Clin Exp Metastasis; 2020 Feb; 37(1):115-124. PubMed ID: 31463796
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway.
Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of BZW1 is an independent poor prognosis marker and its down-regulation suppresses lung adenocarcinoma metastasis.
Chiou J; Chang YC; Jan YH; Tsai HF; Yang CJ; Huang MS; Yu YL; Hsiao M
Sci Rep; 2019 Oct; 9(1):14624. PubMed ID: 31601833
[TBL] [Abstract][Full Text] [Related]
7. Relationship between circulating lung-specific X protein messenger ribonucleic acid expression and micrometastasis and prognosis in patients with early-stage nonsmall cell lung cancer.
Cui Y; Wang W; Yao S; Qiu Z; Cong L
J Cancer Res Ther; 2020; 16(7):1641-1647. PubMed ID: 33565511
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cofilin‑1 and Twist‑1 protein expression in human non‑small cell lung cancer tissues.
Chang CY; Chang SL; Leu JD; Chang YC; Hsiao M; Lin LT; Lin HN; Lee YJ
Oncol Rep; 2019 Aug; 42(2):805-816. PubMed ID: 31233187
[TBL] [Abstract][Full Text] [Related]
9. CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A.
Xu N; Liu F; Wu S; Ye M; Ge H; Zhang M; Song Y; Tong L; Zhou J; Bai C
BMC Cancer; 2020 Mar; 20(1):262. PubMed ID: 32228507
[TBL] [Abstract][Full Text] [Related]
10. Preoperative AminoIndex Cancer Screening (AICS) abnormalities predict postoperative recurrence in patients undergoing curative resection for non-small cell lung cancer.
Higashiyama M; Miyazaki R; Yamamoto H; Anayama T; Kikuchi S; Hirohashi K; Okami J; Maniwa T; Kimura T; Orihashi K; Imamura F
BMC Cancer; 2020 Nov; 20(1):1100. PubMed ID: 33183251
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of nuclear factor of activated T-cells 5 expression in non-small cell lung cancer patients who underwent surgical resection.
Cho HJ; Yun HJ; Yang HC; Kim SJ; Kang SK; Che C; Lee SD; Kang MW
J Surg Res; 2018 Jun; 226():40-47. PubMed ID: 29661287
[TBL] [Abstract][Full Text] [Related]
12. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.
Qian Y; Du Z; Xing Y; Zhou T; Chen T; Shi M
Mol Med Rep; 2017 Nov; 16(5):6034-6040. PubMed ID: 28849037
[TBL] [Abstract][Full Text] [Related]
13. Follistatin-like Protein 1 Inhibits Lung Cancer Metastasis by Preventing Proteolytic Activation of Osteopontin.
Chiou J; Chang YC; Tsai HF; Lin YF; Huang MS; Yang CJ; Hsiao M
Cancer Res; 2019 Dec; 79(24):6113-6125. PubMed ID: 31653686
[TBL] [Abstract][Full Text] [Related]
14. Lysyl oxidase may play a critical role in hypoxia-induced NSCLC cells invasion and migration.
Wei L; Song XR; Sun JJ; Wang XW; Xie L; Lv LY
Cancer Biother Radiopharm; 2012 Dec; 27(10):672-7. PubMed ID: 23140307
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of CUG-binding protein 1 expression and vascular invasion after radical surgery for stage IB nonsmall cell lung cancer.
Zhao J; Zhao Y; Xuan Y; Jiao W; Qiu T; Wang Z; Luo Y
Indian J Cancer; 2015 Dec; 52 Suppl 2():e125-9. PubMed ID: 26728670
[TBL] [Abstract][Full Text] [Related]
16. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
[TBL] [Abstract][Full Text] [Related]
17. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
Zheng J; Xu T; Chen F; Zhang Y
Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of 17‑β‑hydroxysteroid dehydrogenase type 2 and its prognostic significance in non‑small cell lung cancer.
Drzewiecka H; Jarmołowska-Jurczyszyn D; Kluk A; Gałęcki B; Dyszkiewicz W; Jagodziński PP
Int J Oncol; 2020 Jun; 56(6):1352-1372. PubMed ID: 32236582
[TBL] [Abstract][Full Text] [Related]
19. TIPE3 differentially modulates proliferation and migration of human non-small-cell lung cancer cells via distinct subcellular location.
Wang G; Guo C; Zhao H; Pan Z; Zhu F; Zhang L; Wang Q
BMC Cancer; 2018 Mar; 18(1):260. PubMed ID: 29510688
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]